JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

JNJ

167.36

+1.16%↑

NVS

115.01

+0.83%↑

ABT

127.26

-0.02%↓

TMO

462

-2.63%↓

ISRG

480.55

-1.3%↓

Search

Pulse Biosciences Inc

Open

SectorGezondheidszorg

14.75 1.1

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

14.52

Max

15.04

Belangrijke statistieken

By Trading Economics

Inkomsten

2.6M

-17M

Verkoop

832K

832K

Winstmarge

-2,018.63

Werknemers

75

EBITDA

1.9M

-18M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+49.36% upside

Dividenden

By Dow Jones

Volgende Winsten

12 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-184M

1B

Vorige openingsprijs

13.65

Vorige sluitingsprijs

14.75

Nieuwssentiment

By Acuity

50%

50%

162 / 375 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 jul 2025, 23:56 UTC

Populaire aandelen

Stocks to Watch: Amazon, Bio-Rad, Coinbase, Mercer

31 jul 2025, 23:48 UTC

Marktinformatie

Scentre Can Beat Annual Earnings Guidance -- Market Talk

31 jul 2025, 23:45 UTC

Marktinformatie

Nikkei May Decline Amid Caution Over Earnings, Domestic Politics -- Market Talk

31 jul 2025, 23:37 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

31 jul 2025, 23:37 UTC

Marktinformatie

Gold Steady as Traders Eye Tariff-Deal Developments -- Market Talk

31 jul 2025, 23:12 UTC

Winsten

OCBC: Evolving Trade, Monetary Policies, Persistent Geopolitical Tensions Expected to Weigh on Growth Prospects >O39.SG

31 jul 2025, 23:10 UTC

Winsten

Oversea-Chinese Banking: Declining Interest-Rate Environment Weighed in Net Interest Income >O39.SG

31 jul 2025, 23:09 UTC

Winsten

Oversea-Chinese Banking 2Q Net Interest Income S$2.28B Vs. S$2.43B >O39.SG

31 jul 2025, 23:08 UTC

Winsten

Oversea-Chinese Banking 2Q Total Income S$3.55B Vs. S$3.63B >O39.SG

31 jul 2025, 23:08 UTC

Winsten

Oversea-Chinese Banking 2Q Net S$1.82B Vs. Net S$1.94B >O39.SG

31 jul 2025, 23:01 UTC

Winsten

Amazon Posts Higher Sales, Profit -- 3rd Update

31 jul 2025, 22:08 UTC

Marktinformatie
Winsten

Amazon CEO Impressed by Deals Signed for Project Kuiper -- Market Talk

31 jul 2025, 22:02 UTC

Marktinformatie
Winsten

Apple's FY Outlook Shows Sales Growth Won't Last -- Market Talk

31 jul 2025, 21:57 UTC

Marktinformatie
Winsten

Amazon CEO Sees Strong Early Demand for Alexa+ -- Market Talk

31 jul 2025, 21:50 UTC

Winsten

Amazon Earnings Beat Expectations. Why the Stock Is Falling. -- Barrons.com

31 jul 2025, 21:43 UTC

Winsten

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- 2nd Update

31 jul 2025, 21:29 UTC

Winsten

Amazon to Invest More in Chips, Data Centers Amid Generative AI Opportunity, CFO Says

31 jul 2025, 21:26 UTC

Winsten

Apple Expects Revenue to Grow in Mid- to High-Single Digits in Current Quarter, CFO Says

31 jul 2025, 21:26 UTC

Winsten

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

31 jul 2025, 21:22 UTC

Winsten

Amazon Has Impressive Amount of Agreements for Project Kuiper, CEO Says

31 jul 2025, 21:19 UTC

Winsten

Apple Estimates Tariff Impact to Add $1.1B to Costs in Current Quarter, CEO Says

31 jul 2025, 21:19 UTC

Winsten

Apple Incurred $800M in Tariff-Related Costs in 2Q, CEO Says

31 jul 2025, 21:14 UTC

Winsten

Amazon's AWS is Seeing More Demand Than Supply, CEO Says

31 jul 2025, 21:12 UTC

Winsten

Amazon Saw Record Prime Sign-Ups in 3 Weeks Before Prime Day, CEO Says

31 jul 2025, 21:10 UTC

Winsten

Amazon Just Getting Started on Automation, Robotics to Boost Efficiency, CEO Says

31 jul 2025, 21:09 UTC

Winsten

Amazon Delivered to Prime Members at Record Pace in 2Q, CEO Says

31 jul 2025, 21:09 UTC

Winsten

Amazon CEO Sees Diversity of Sellers as Advantage for Inflation-Weary Consumers

31 jul 2025, 21:08 UTC

Winsten

Apple iPhone Revenue Performance Driven by Popularity of iPhone 16 Family, CEO Says

31 jul 2025, 21:08 UTC

Winsten

Amazon CEO Sees Strong Customer Adoption of Perishables Same-Day Delivery Pilot

31 jul 2025, 21:05 UTC

Winsten

Apple's iPhone Sales Blow Past Estimates as Customers Raced to Beat Tariffs -- Update

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

49.36% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 22 USD  49.36%

Hoogste 22 USD

Laagste 22 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

162 / 375 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.